Companies: 10,795·Total market cap: $144.5T
Innovation Pharmaceuticals Inc.

Innovation Pharmaceuticals Inc.

IPIXOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$155504
P/E Ratio—
52W High$0.05
52W Low$0.00001
Overview

Innovation Pharmaceuticals Inc. (IPIX) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · IPIX · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2023-062022-062021-062020-062019-06
Operating Activities
Net Income($0.00B)($0.01B)($0.01B)($0.01B)($0.01B)
Depreciation & Amort.$0.00B$0.00B$0.00B$0.00B$0.00B
Stock-Based Comp.$0.00B$0.00B$0.00B$0.00B$0.00B
Change in Working Capital$0.00B($0.00B)($0.00B)($0.00B)($0.00B)
Net Cash from Operations($0.00B)($0.01B)($0.01B)($0.00B)($0.01B)
Investing Activities
Capital Expenditure($0.00B)($0.00B)($0.00B)($0.00B)($0.00B)
Purchases of Investments$0.00B$0.00B$0.00B$0.00B$0.00B
Sales of Investments$0.00B$0.00B$0.00B$0.00B$0.00B
Net Cash from Investing($0.00B)($0.00B)($0.00B)($0.00B)($0.00B)
Financing Activities
Common Stock Repurchased$0.00B$0.00B($0.00B)($0.00B)($0.00B)
Dividends Paid($0.00B)$0.00B$0.00B$0.00B$0.00B
Debt Issued / Repaid($0.00B)($0.00B)$0.00B$0.00B$0.00B
Net Cash from Financing($0.00B)$0.00B$0.01B$0.01B$0.00B
Free Cash Flow
Free Cash Flow($0.00B)($0.01B)($0.01B)($0.00B)($0.01B)
FCF Margin %(computed)—————

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B

SEC 10-K filings →SEC 10-Q filings →

Explore more Innovation Pharmaceuticals Inc. data

Revenue History
Quarterly & annual revenue trends
Earnings Reports
EPS beats, misses & upcoming dates
P/E Ratio
Historical price-to-earnings
Dividends
Dividend history & yield
Market Cap
Historical market cap & rank
Analyst Forecast
Consensus, price targets & estimates

About Innovation Pharmaceuticals Inc. (IPIX) Cash Flow Statement

Innovation Pharmaceuticals Inc. generated operating cash flow of ($0.00B) and free cash flow of ($0.00B) for 2023 — a FCF margin of —. Capital expenditure was ($0.00B).

Frequently asked questions

IPIX · 4 questions

Innovation Pharmaceuticals Inc. generated free cash flow of ($0.00B) for 2023, up 65.9% year-over-year.

IPIX free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10